Anne M Presanis
Overview
Explore the profile of Anne M Presanis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
2235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirwan P, Foulkes S, Munro K, Sparkes D, Singh J, Henry A, et al.
J Infect
. 2024 Sep;
89(5):106293.
PMID: 39343245
Objectives: Bivalent original/BA.4-5 and monovalent XBB.1.5 mRNA boosters were offered to UK healthcare workers (HCWs) in the autumn of 2023. We aimed to estimate booster vaccine effectiveness (VE) and post-infection...
2.
Samartsidis P, Harris R, Dillon J, Desai M, Foster G, Gunson R, et al.
Int J Drug Policy
. 2024 Jun;
:104429.
PMID: 38942687
Background: There is limited empirical work assessing the effectiveness of treatment as prevention (TasP) in reducing HCV prevalence among people who inject drugs (PWID). Here, we used survey data from...
3.
Muschialli L, Samartsidis P, Presanis A, Mercer C
BMC Public Health
. 2024 Feb;
24(1):366.
PMID: 38310277
Background: Understanding sexual lifestyles and how they change over time is important for determining the likelihood of sexual health outcomes. Standard descriptive and regression methods are limited in their ability...
4.
Heath B, Evans S, Robertson D, Robotham J, Villar S, Presanis A
BMC Infect Dis
. 2023 Dec;
23(1):900.
PMID: 38129789
Background: There is evidence that during the COVID pandemic, a number of patient and HCW infections were nosocomial. Various measures were put in place to try to reduce these infections...
5.
Kirwan P, Hall V, Foulkes S, Otter A, Munro K, Sparkes D, et al.
Lancet Reg Health Eur
. 2023 Dec;
36:100809.
PMID: 38111727
Background: The protection of fourth dose mRNA vaccination against SARS-CoV-2 is relevant to current global policy decisions regarding ongoing booster roll-out. We aimed to estimate the effect of fourth dose...
6.
Nyberg T, Bager P, Svalgaard I, Bejko D, Bundle N, Evans J, et al.
Euro Surveill
. 2023 Sep;
28(36).
PMID: 37676146
Several SARS-CoV-2 variants that evolved during the COVID-19 pandemic have appeared to differ in severity, based on analyses of single-country datasets. With decreased testing and sequencing, international collaborative studies will...
7.
Muhammed F, Belay D, Presanis A, Sebu A
Sci Afr
. 2023 Jan;
19:e01519.
PMID: 36691645
A Bayesian joint modeling approach to dynamic prediction of HIV progression and mortality allows individualized predictions to be made for HIV patients, based on monitoring of their CD4 counts. This...
8.
Stimson J, Pouwels K, Hope R, Cooper B, Presanis A, Robotham J
BMC Infect Dis
. 2022 Dec;
22(1):922.
PMID: 36494640
Background: From March 2020 through August 2021, 97,762 hospital-onset SARS-CoV-2 infections were detected in English hospitals. Resulting excess length of stay (LoS) created a potentially substantial health and economic burden...
9.
Nyberg T, Ferguson N, Blake J, Hinsley W, Bhatt S, De Angelis D, et al.
Lancet
. 2022 Sep;
400(10355):809-810.
PMID: 36088947
No abstract available.
10.
Kirwan P, Charlett A, Birrell P, Elgohari S, Hope R, Mandal S, et al.
Nat Commun
. 2022 Aug;
13(1):4834.
PMID: 35977938
Widespread vaccination campaigns have changed the landscape for COVID-19, vastly altering symptoms and reducing morbidity and mortality. We estimate trends in mortality by month of admission and vaccination status among...